Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23576482)

1.

Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Lowery AJ, Walsh S, McDermott EW, Prichard RS.

Oncologist. 2013;18(4):391-407. doi: 10.1634/theoncologist.2012-0410. Epub 2013 Apr 10. Review.

2.

Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Gimm O, DeMicco C, Perren A, Giammarile F, Walz MK, Brunaud L.

Langenbecks Arch Surg. 2012 Feb;397(2):155-77. doi: 10.1007/s00423-011-0880-x. Epub 2011 Nov 29. Review.

PMID:
22124609
3.

Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.

Welander J, Söderkvist P, Gimm O.

Endocr Relat Cancer. 2011 Dec 1;18(6):R253-76. doi: 10.1530/ERC-11-0170. Print 2011 Dec. Review.

4.

Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.

Fishbein L, Orlowski R, Cohen D.

J Clin Hypertens (Greenwich). 2013 Jun;15(6):428-34. doi: 10.1111/jch.12084. Epub 2013 Mar 15. Review.

PMID:
23730992
5.

Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.

Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, van Heerden J, Lteif AN, Young WF Jr.

Pediatrics. 2006 Sep;118(3):1109-17.

PMID:
16951005
6.

Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.

de Cubas AA, Leandro-García LJ, Schiavi F, Mancikova V, Comino-Méndez I, Inglada-Pérez L, Perez-Martinez M, Ibarz N, Ximénez-Embún P, López-Jiménez E, Maliszewska A, Letón R, Gómez Graña A, Bernal C, Alvarez-Escolá C, Rodríguez-Antona C, Opocher G, Muñoz J, Megias D, Cascón A, Robledo M.

Endocr Relat Cancer. 2013 Jun 24;20(4):477-93. doi: 10.1530/ERC-12-0183. Print 2013 Aug.

7.

An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.

Gimenez-Roqueplo AP, Dahia PL, Robledo M.

Horm Metab Res. 2012 May;44(5):328-33. doi: 10.1055/s-0031-1301302. Epub 2012 Feb 10. Review.

PMID:
22328163
8.

Clinical management of paragangliomas.

Corssmit EP, Romijn JA.

Eur J Endocrinol. 2014 Dec;171(6):R231-43. doi: 10.1530/EJE-14-0396. Epub 2014 Jul 25. Review.

9.

Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.

Walz MK, Peitgen K, Neumann HP, Janssen OE, Philipp T, Mann K.

World J Surg. 2002 Aug;26(8):1005-12. Epub 2002 Jun 6.

PMID:
12045858
10.

Hereditary pheochromocytoma and paraganglioma.

Mazzaglia PJ.

J Surg Oncol. 2012 Oct 1;106(5):580-5. doi: 10.1002/jso.23157. Epub 2012 May 30. Review.

PMID:
22648936
11.

Outcomes of pheochromocytoma management in the laparoscopic era.

Solorzano CC, Lew JI, Wilhelm SM, Sumner W, Huang W, Wu W, Montano R, Sleeman D, Prinz RA.

Ann Surg Oncol. 2007 Oct;14(10):3004-10. Epub 2007 Aug 10.

PMID:
17690941
12.

The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Shuch B, Ricketts CJ, Metwalli AR, Pacak K, Linehan WM.

Urology. 2014 Jun;83(6):1225-32. doi: 10.1016/j.urology.2014.01.007. Epub 2014 Mar 15. Review.

PMID:
24642075
13.

[Pediatric pheochromocytoma and paraganglioma: an update].

Garnier S, Réguerre Y, Orbach D, Brugières L, Kalfa N.

Bull Cancer. 2014 Oct;101(10):966-75. doi: 10.1684/bdc.2014.2031. Review. French.

PMID:
25373696
14.

Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.

Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K.

Endocr Relat Cancer. 2009 Jun;16(2):391-400. doi: 10.1677/ERC-08-0284. Epub 2009 Feb 3. Review.

15.

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Nölting S, Grossman AB.

Endocr Pathol. 2012 Mar;23(1):21-33. doi: 10.1007/s12022-012-9199-6. Review.

PMID:
22391976
16.

[Diagnosis of and surgical therapy for pheochromocytoma and paraganglioma].

Musholt TJ.

Zentralbl Chir. 2010 Jun;135(3):226-32. doi: 10.1055/s-0030-1247315. Epub 2010 Jun 14. Review. German.

PMID:
20549585
17.

Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.

Korpershoek E, Petri BJ, van Nederveen FH, Dinjens WN, Verhofstad AA, de Herder WW, Schmid S, Perren A, Komminoth P, de Krijger RR.

Endocr Relat Cancer. 2007 Jun;14(2):453-62.

18.

New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas.

de Krijger RR, van Nederveen FH, Korpershoek E, Dinjens WN.

Endocr Pathol. 2006 Summer;17(2):137-41. Review.

PMID:
17159246
19.

Phaeochromocytomas and sympathetic paragangliomas.

Petri BJ, van Eijck CH, de Herder WW, Wagner A, de Krijger RR.

Br J Surg. 2009 Dec;96(12):1381-92. doi: 10.1002/bjs.6821. Review.

PMID:
19918850
20.

[Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].

van der Kleij-Corssmit EP, Havekes B, Vriends AH, Jansen JC, Romijn JA.

Ned Tijdschr Geneeskd. 2008 Mar 1;152(9):489-93. Review. Dutch.

PMID:
18389879
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk